AI‐Driven Rational Design of Nanotherapeutics for Pancreatic Ductal Adenocarcinoma

{"Pancreatic":[0],"ductal":[1],"adenocarcinoma":[2],"(PDAC)":[3],"remains":[4],"a":[5],"formidable":[6],"malignancy":[7],"characterized":[8],"by":[9],"late":[10],"diagnosis,":[11],"high":[12],"recurrence":[13],"rates,":[14],"and":[15,47,54,77,94,103,120,128,145,167],"pronounced":[16],"chemoresistance.":[17],"While":[18],"nanoparticle-based":[19],"drug":[20,126],"delivery":[21],"systems":[22,97],"(NDDS)":[23],"offer":[24],"theoretical":[25],"advantages":[26],"over":[27],"conventional":[28],"therapies,":[29],"their":[30],"clinical":[31],"translation":[32],"in":[33,123,139],"PDAC":[34],"has":[35],"been":[36],"severely":[37],"limited.":[38],"The":[39],"dense":[40],"desmoplastic":[41],"stroma,":[42],"elevated":[43],"interstitial":[44],"fluid":[45],"pressure,":[46],"hypovascularity":[48],"effectively":[49],"neutralize":[50],"the":[51,63,113,146,153,173],"enhanced":[52],"permeability":[53],"retention":[55],"(EPR)":[56],"effect,":[57],"restricting":[58],"passive":[59],"nanoparticle":[60,130],"penetration.":[61],"Consequently,":[62],"therapeutic":[64],"paradigm":[65],"is":[66],"shifting":[67],"from":[68],"indiscriminate":[69],"stromal":[70,75],"depletion-which":[71],"paradoxically":[72],"accelerates":[73],"metastasis-to":[74],"normalization":[76],"immune":[78],"microenvironment":[79],"reprogramming.":[80],"This":[81],"review":[82,171],"comprehensively":[83],"evaluates":[84],"advanced":[85],"NDDS":[86,163],"platforms,":[87],"highlighting":[88],"transcytosis-triggering":[89],"active":[90],"targeting,":[91],"stimuli-responsive":[92],"carriers,":[93],"multimodal":[95],"theranostic":[96],"designed":[98],"to":[99,108],"bypass":[100],"physical":[101],"barriers":[102],"convert":[104],"immunologically":[105],"\\"cold\\"":[106],"tumors":[107],"\\"hot.\\"":[109],"Furthermore,":[110],"we":[111,134],"analyze":[112],"expanding":[114],"role":[115],"of":[116,155],"artificial":[117],"intelligence":[118],"(AI)":[119],"machine":[121],"learning":[122],"predicting":[124],"synergistic":[125],"combinations":[127],"optimizing":[129],"physicochemical":[131],"properties.":[132],"Crucially,":[133],"critique":[135],"current":[136],"epistemic":[137],"limitations":[138],"AI-driven":[140],"nanomedicine,":[141],"particularly":[142],"data":[143],"sparsity":[144],"reliance":[147],"on":[148],"2D":[149],"preclinical":[150],"models,":[151],"emphasizing":[152],"necessity":[154],"3D":[156],"patient-derived":[157],"organoid":[158],"validation.":[159],"By":[160],"integrating":[161],"rational":[162],"design":[164],"with":[165],"AI":[166],"biomarker-driven":[168],"strategies,":[169],"this":[170],"maps":[172],"essential":[174],"pathways":[175],"toward":[176],"personalized":[177],"nanotherapeutics":[178],"for":[179],"PDAC.":[180]}

Authors

Institutions

Publication Details

Journal
Medicinal Research Reviews
Published
2026-09-05
DOI
https://doi.org/10.1002/med.70105
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

AI‐Driven Rational Design of Nanotherapeutics for Pancreatic Ductal Adenocarcinoma

Inseon Kim, Seunghun S. Lee, Kaeun Chae, Seohyun Choo et al.
Medicinal Research Reviews
Pancreatic and Hepatic Oncology Research
article

AI‐Driven Rational Design of Nanotherapeutics for Pancreatic Ductal Adenocarcinoma

Inseon Kim, Seunghun S. Lee, Kaeun Chae, Seohyun Choo, Jueun Lee
article en

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains a formidable malignancy characterized by late diagnosis, high recurrence rates, and pronounced chemoresistance. While nanoparticle-based drug delivery systems (NDDS) offer theoretical advantages over conventional therapies, their clinical translation in PDAC has been severely limited. The dense desmoplastic stroma, elevated interstitial fluid pressure, and hypovascularity effectively neutralize the enhanced permeability and retention (EPR) effect, restricting passive nanoparticle penetration. Consequently, the therapeutic paradigm is shifting from indiscriminate stromal depletion-which paradoxically accelerates metastasis-to stromal normalization and immune microenvironment reprogramming. This review comprehensively evaluates advanced NDDS platforms, highlighting transcytosis-triggering active targeting, stimuli-responsive carriers, and multimodal theranostic systems designed to bypass physical barriers and convert immunologically "cold" tumors to "hot." Furthermore, we analyze the expanding role of artificial intelligence (AI) and machine learning in predicting synergistic drug combinations and optimizing nanoparticle physicochemical properties. Crucially, we critique current epistemic limitations in AI-driven nanomedicine, particularly data sparsity and the reliance on 2D preclinical models, emphasizing the necessity of 3D patient-derived organoid validation. By integrating rational NDDS design with AI and biomarker-driven strategies, this review maps the essential pathways toward personalized nanotherapeutics for PDAC.

Medicinal Research Reviews
Dongguk University (KR)
Korea Institute for Advancement of Technology, National Research Foundation of Korea
Reduced inequalities
Openalex Percentile: Top 13%
Pancreatic and Hepatic Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.